Skip to main content
GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
7.08
+0.12 (1.72%)
At close: Apr 25, 2024, 4:00 PM
6.92
-0.16 (-2.26%)
After-hours: Apr 25, 2024, 4:39 PM EDT

GoodRx Holdings Revenue

In the year 2023, GoodRx Holdings had annual revenue of $750.27M, a decrease of -2.12%. Revenue in the quarter ending December 31, 2023 was $196.64M with 6.81% year-over-year growth.

Revenue (ttm)
$750.27M
Revenue Growth
-2.12%
P/S Ratio
3.73
Revenue / Employee
$1,081,073
Employees
694
Market Cap
2.80B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023750.27M-16.29M-2.12%
Dec 31, 2022766.55M21.13M2.83%
Dec 31, 2021745.42M194.72M35.36%
Dec 31, 2020550.70M162.48M41.85%
Dec 31, 2019388.22M138.70M55.59%
Dec 31, 2018249.52M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 3.00B
Neogen 929.24M
ACADIA Pharmaceuticals 726.44M
Azenta 641.02M
MorphoSys AG 264.75M
Immunocore Holdings 249.43M
Arrowhead Pharmaceuticals 181.74M
Olink Holding AB (publ) 169.60M
Revenue Rankings

GDRX News

More News